Published in Medical Letter on the CDC and FDA, November 6th, 1995
Prophylactic therapy with isoniazid is the established regimen for those infected with drug-sensitive strains of M. tuberculosis, but in those presumed to be infected with resistant strains the appropriate course of preventive therapy is not clear.
Prophylaxis with ciprofloxacin, 750 mg twice daily, and pyrazinamide, 25 to 30 mg/kg per day in three divided doses for six to twelve months has...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.